# OnCo record lvgn6051 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/lvgn6051/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "lvgn6051" ;
  schema:name "LVGN6051"@en ;
  schema:description "LVGN6051 is a monoclonal antibody from Lyvgen Biopharma Holdings Limited, in registered phase 2 trials for head and neck squamous cell carcinoma."@en ;
  schema:url <https://onco.cc/drugs/lvgn6051/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=LVGN6051> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest", "registry-only" ;
  onco:modality "Monoclonal antibody" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/> ;
  onco:companies <https://onco.cc/companies/lyvgen-biopharma/> ;
  onco:trials <https://onco.cc/trials/nct06378177/> .